Skip to main content
. 2016 May 15;8(5):474–480. doi: 10.4251/wjgo.v8.i5.474

Table 2.

Pathological staging post simultaneous integrated boost based neoadjuvant chemoradiation

Pathological staging Patient n (%)
ypT
0 8 (47)
1 4 (23)
2 3 (18)
3 2 (12)
4 0
ypN
0 13 (76.5)
1 4 (23.5)